Skip to content

The use of electromagnetic transduction therapy in patients with chronic myofascial pain attending an outpatient pain management clinic: a pilot feasibility randomized controlled trial

The use of electromagnetic transduction therapy in patients with chronic myofascial pain attending an outpatient pain management clinic: a pilot feasibility randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021031
Enrollment
Unknown
Registered
2018-12-07
Start date
2020-09-01
Completion date
Unknown
Last updated
2023-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic myofascial pain

Interventions

Two groups:80mT with an impulse frequency of 3Hz & electric power of 30kV 20 minutes, 8 sessions over 4 weeks versus conventional treatment 20 minutes, 8 sessions over 4 weeks

Sponsors

Department of Anaesthesia & Intensive Care, CUHK
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Aged 18 to 85 year old patients who have moderate to severe myofascial pain lasting for more than 3 months and are able to complete questionnaires will be invited into this study. Pain severity with reported NRS >= 5 on a scale out of 10 will be defined as moderate to severe. Patients with more than 1 myosfacial pain region will receive therapy to the most distressing region.

Exclusion criteria

Exclusion criteria: Pregnant, illiterate, with pain severity NRS = 4 painful areas), having on-going litigation or compensation issue and significant psychiatric disorders with psychotic features or history of suicidal attempt. Patients who have contraindications to EMTT therapy will be excluded as well.

Design outcomes

Primary

MeasureTime frame
Pain intensity;

Secondary

MeasureTime frame
Non symptomatic aspects of pain i.e. Physical functioning, mood and global improvement, determination of their clinically importance, & any adverse reactionof;

Countries

China

Contacts

Public ContactDr Cheuk Yin Li

Anaesthesia & Intensive Care, The Chinese University of Hong Kong

arahaha@cuhk.edu.hk+852 35052734

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026